Danaher 

€166.02
1277
+€1.08+0.65% Thursday 15:32

Statistics

Day High
166.02
Day Low
163.34
52W High
208
52W Low
153.52
Volume
0
Avg. Volume
4
Mkt Cap
117.4B
P/E Ratio
30.01
Dividend Yield
0.83%
Dividend
1.39

Upcoming

Dividends

0.83%Dividend Yield
Apr 26
€0.35
Jan 26
€0.27
Oct 25
€0.27
Jul 25
€0.27
Apr 25
€0.3
10Y Growth
11.98%
5Y Growth
13.99%
3Y Growth
12.76%
1Y Growth
24.45%

Earnings

21AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.57
1.79
2.01
2.23
Expected EPS
1.93844
Actual EPS
N/A

Financials

14.73%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
42.3BRevenue
6.23BNet Income

Analyst Ratings

$195.39Average Price Target
The highest estimate is 208.67.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DHRC.VI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific competes directly with Danaher in the life sciences and diagnostics sectors, offering similar products and services.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, competes in the biopharmaceuticals sector, overlapping with Danaher's life sciences division.
GE Aerospace
GE
Mkt Cap325.88B
General Electric's healthcare division competes with Danaher in medical diagnostics and research products.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company offers a range of medical devices and laboratory equipment, competing with Danaher's life sciences and diagnostics segments.
Resmed
RMD
Mkt Cap36.04B
ResMed competes in the medical devices sector, particularly in products for sleep disorders, overlapping with Danaher's respiratory and sleep business.
Stryker
SYK
Mkt Cap136.19B
Stryker operates in the medical technology field, offering products that compete with Danaher's medical and dental products.
Danaher
DHR
Mkt Cap152.13B
Danaher competes with itself through its diverse portfolio of subsidiaries, each operating in similar sectors as its competitors.
Mettler-Toledo International
MTD
Mkt Cap29.17B
Mettler-Toledo International competes in the precision instruments sector, offering products that overlap with Danaher's analytical and diagnostic solutions.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies competes with Danaher in the life sciences, diagnostics, and applied chemical markets, offering similar analytical instruments and services.

About

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
Show more...
CEO
Mr. Steven M. Rales
Employees
78000
Country
United States
ISIN
US2358511028

Listings

0 Comments

Share your thoughts

FAQ

What is Danaher stock price today?
The current price of DHRC.VI is €166.02 EUR — it has increased by +0.65% in the past 24 hours. Watch Danaher stock price performance more closely on the chart.
What is Danaher stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Danaher stocks are traded under the ticker DHRC.VI.
Is Danaher stock price growing?
DHRC.VI stock has risen by +4.35% compared to the previous week, the month change is a -5.78% fall, over the last year Danaher has showed a -4.61% decrease.
What is Danaher market cap?
Today Danaher has the market capitalization of 117.4B
When is the next Danaher earnings date?
Danaher is going to release the next earnings report on April 21, 2026.
What were Danaher earnings last quarter?
DHRC.VI earnings for the last quarter are 1.86 EUR per share, whereas the estimation was 1.81 EUR resulting in a +3.11% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Danaher revenue for the last year?
Danaher revenue for the last year amounts to 42.3B EUR.
What is Danaher net income for the last year?
DHRC.VI net income for the last year is 6.23B EUR.
Does Danaher pay dividends?
Yes, DHRC.VI dividends are paid quarterly. The last dividend per share was 0.27 EUR. As of today, Dividend Yield (FWD)% is 0.83%.
How many employees does Danaher have?
As of April 04, 2026, the company has 78,000 employees.
In which sector is Danaher located?
Danaher operates in the Healthcare sector.
When did Danaher complete a stock split?
The last stock split for Danaher was on June 14, 2010 with a ratio of 2:1.
Where is Danaher headquartered?
Danaher is headquartered in Washington, United States.